Medistim ASA Cash Flow Reinvestment Rate
Medistim ASA cash flow reinvestment rate. Medistim ASA (MEDI) has a Cash Flow Reinvestment Rate of 0.21x as of June 2025, reinvesting Nkr8.01 Million (capex Nkr0.00 plus investments Nkr-8.01 Million) from operating cash flow of Nkr37.65 Million. See how financially flexible is Medistim ASA to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Medistim ASA (2004–2024)
Cash flow reinvestment rate of Medistim ASA from 2004 to 2024. Historical reinvestment intensity for Medistim ASA across 21 annual periods. Explore MEDI cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Medistim ASA Cash Flow Reinvestment Rate by Year (2004–2024)
Medistim ASA cash flow reinvestment rate by year from 2004 to 2024. Year-by-year capital reinvestment analysis for Medistim ASA. For the full cash flow conversion analysis, see cash flow conversion of Medistim ASA.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.35x | Nkr49.39 Million | Nkr143.10 Million | Nkr24.69 Million | ▼ -34.3% |
| 2023 | 0.53x | Nkr59.45 Million | Nkr113.19 Million | Nkr29.73 Million | ▲ +98.2% |
| 2022 | 0.26x | Nkr30.35 Million | Nkr114.56 Million | Nkr9.25 Million | ▲ +47.8% |
| 2021 | 0.18x | Nkr22.97 Million | Nkr128.14 Million | Nkr11.49 Million | ▼ -37.5% |
| 2020 | 0.29x | Nkr21.28 Million | Nkr74.13 Million | Nkr10.64 Million | ▼ -15.7% |
| 2019 | 0.34x | Nkr27.36 Million | Nkr80.38 Million | Nkr13.68 Million | ▼ -42.0% |
| 2018 | 0.59x | Nkr32.74 Million | Nkr55.79 Million | Nkr16.37 Million | ▲ +21.8% |
| 2017 | 0.48x | Nkr28.96 Million | Nkr60.10 Million | Nkr14.48 Million | ▼ -45.4% |
| 2016 | 0.88x | Nkr26.91 Million | Nkr30.47 Million | Nkr13.46 Million | ▲ +234.9% |
| 2015 | 0.26x | Nkr11.78 Million | Nkr44.66 Million | Nkr11.78 Million | ▼ -10.8% |
| 2014 | 0.30x | Nkr14.47 Million | Nkr48.94 Million | Nkr14.47 Million | ▼ -64.8% |
| 2013 | 0.84x | Nkr21.85 Million | Nkr26.04 Million | Nkr21.85 Million | ▲ +240.0% |
| 2012 | 0.25x | Nkr6.48 Million | Nkr26.25 Million | Nkr6.48 Million | ▼ -46.1% |
| 2011 | 0.46x | Nkr11.30 Million | Nkr24.66 Million | Nkr11.30 Million | ▲ +244.0% |
| 2010 | 0.13x | Nkr4.96 Million | Nkr37.27 Million | Nkr4.96 Million | — |
| 2009 | 0.00x | Nkr0.00 | Nkr32.78 Million | Nkr0.00 | ▼ -100.0% |
| 2008 | 0.34x | Nkr9.20 Million | Nkr26.76 Million | Nkr9.20 Million | ▼ -4.7% |
| 2007 | 0.36x | Nkr7.50 Million | Nkr20.80 Million | Nkr7.50 Million | ▲ +2.4% |
| 2006 | 0.35x | Nkr6.09 Million | Nkr17.31 Million | Nkr6.09 Million | ▼ -5.7% |
| 2005 | 0.37x | Nkr5.56 Million | Nkr14.89 Million | Nkr5.56 Million | ▼ -8.0% |
| 2004 | 0.41x | Nkr2.19 Million | Nkr5.39 Million | Nkr2.19 Million | — |